Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and … Read more
Market Cap & Net Worth: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130)
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (SHE:301130) has a market capitalization of $331.32 Million (CN¥2.43 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #15796 globally and #4228 in its home market, demonstrating a -0.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's stock price CN¥31.78 by its total outstanding shares 76494685 (76.49 Million).
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd Market Cap History: 2022 to 2026
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's market capitalization history from 2022 to 2026. Data shows change from $295.97 Million to $331.32 Million (-12.98% CAGR).
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.07x
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's market cap is 1.07 times its annual revenue
1.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
6.80x
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's market cap is 6.80 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $295.97 Million | $255.47 Million | $40.72 Million | 1.16x | 7.27x |
| 2023 | $287.51 Million | $225.49 Million | $50.50 Million | 1.28x | 5.69x |
| 2024 | $273.67 Million | $256.41 Million | $40.27 Million | 1.07x | 6.80x |
Competitor Companies of 301130 by Market Capitalization
Companies near Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd Historical Marketcap From 2022 to 2026
Between 2022 and today, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's market cap moved from $295.97 Million to $ 331.32 Million, with a yearly change of -12.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥331.32 Million | +11.35% |
| 2025 | CN¥297.54 Million | +8.72% |
| 2024 | CN¥273.67 Million | -4.81% |
| 2023 | CN¥287.51 Million | -2.86% |
| 2022 | CN¥295.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.32 Million USD |
| MoneyControl | $331.32 Million USD |
| MarketWatch | $331.32 Million USD |
| marketcap.company | $331.32 Million USD |
| Reuters | $331.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.